Assertio Therapeutics Inc (ASRT) — Capital Reinvestment Ratio
Assertio Therapeutics Inc (ASRT) has a Capital Reinvestment Ratio of 0.03x as of December 2023, meaning it reinvests 0% of its operating cash flow ($5.71 Million) in capital expenditures ($180.00K). See Assertio Therapeutics Inc balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Assertio Therapeutics Inc Capital Reinvestment Ratio (2005–2023)
This chart tracks Assertio Therapeutics Inc's Capital Reinvestment Ratio across 14 annual periods. Check ASRT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Assertio Therapeutics Inc (2005–2023)
Year-by-year Capital Reinvestment Ratio for Assertio Therapeutics Inc from 2005 to 2023. For live market cap and broader valuation context, see Assertio Therapeutics Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.01x | $49.60 Million | $628.00K | ▲ +263.2% |
| 2022 | 0.00x | $78.60 Million | $274.00K | ▼ -63.7% |
| 2021 | 0.01x | $5.52 Million | $53.00K | ▼ -41.4% |
| 2019 | 0.02x | $90.47 Million | $1.48 Million | ▼ -78.5% |
| 2018 | 0.08x | $72.50 Million | $5.51 Million | ▲ +609.1% |
| 2017 | 0.01x | $62.17 Million | $666.00K | ▼ -75.5% |
| 2016 | 0.04x | $65.50 Million | $2.86 Million | ▼ -76.5% |
| 2015 | 0.19x | $143.89 Million | $26.71 Million | ▼ -7.7% |
| 2013 | 0.20x | $9.75 Million | $1.96 Million | ▲ +1561.4% |
| 2011 | 0.01x | $57.65 Million | $698.00K | ▼ -96.5% |
| 2009 | 0.34x | $1.84 Million | $629.00K | ▲ +346.2% |
| 2008 | 0.08x | $3.35 Million | $257.00K | ▲ +620.8% |
| 2007 | 0.01x | $14.66 Million | $156.00K | ▼ -61.2% |
| 2005 | 0.03x | $28.82 Million | $791.25K | — |